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sample of meta-analyses indexed in PsycINFOAMSTAR (A MeaSurement Tool to Assess systematic
Reviews) has been developed by Shea et al. in 2007 [1]
to assess the methodological quality of systematic reviews
and meta-analyses (MA). In 2017, Shea et al. proposed a
revised version of this tool [2]. Recently, Lorenz et al. [3]
published, in this journal, an important article in which
they confirmed the validity of this revised tool and high-
lighted the moderate inter-rater reliability (IRR) of AM-
STAR 2 in a sample of 60 MAs published between 2012
and 2017 in the field of depression.
In the present letter, we propose to assess reliability be-
tween the initial AMSTAR and its revised form, that is,
AMSTAR 2, and to measure IRR of the latter in a larger
sample of 206 MAs published in psychology and related
field. The data were collected previously as part of a larger
project assessing the reporting completeness in MAs pub-
lished in this journal [4].
Following the methodology used in Lorenz’s study,
we calculated the Fleiss’ kappa (K) statistic for dichoto-
mous items and linear weighted kappa for categorical
items to determine the IRR of AMSTAR 2. Then, we
used two analytical approaches to measure the conver-
gent validity between AMSTAR and AMSTAR 2. First,
we evaluated the agreement between the overall rating
for AMSTAR 2 and AMSTAR. Second, the relation
between the number of items fulfilled by each MA
with both tools was evaluated with a Spearman’s
correlation.
Across our sample of 206 MAs, 195 MAs were cate-
gorized as critically low, eight as low, two as moderate,
and one as high using the classification advised by AM-
STAR 2. With the AMSTAR tool and the classification
advised by Lorenz, 51 MAs out of 206 were categorized
as low quality, 131 as medium, and 24 as high (Fig. 1A).
With regards to the IRR, our results were consistent with
the results of Lorenz’s study; the IRR (K) for each of the
items of AMSTAR2 is in the range of 0.12e0.81. AM-
STAR2 has a moderate IRR with a median K of 0.56DOI of original article: https://doi.org/10.1016/j.jclinepi.2019.10.006.
0895-4356/ 2019 Elsevier Inc. All rights reserved.(P25e75: 0.30e0.76). Also in agreement with Lorenz,
we found some degree of concordance between AM-
STAR and AMSTAR 2. All MAs that have not been rated
as critically low with AMSTAR 2 were considered as
moderate or high quality when rated with AMSTAR
(Fig. 1B). Finally, the correlation between the two tools
indicated a strong positive association (r Z 0.84;
P ! 0.001) (Fig. 1C).
In conclusion, consistent with the results from Lorenz’s
study, the IRR for AMSTAR 2 between the two raters
found in our study indicated a moderate agreement in a
sample of 206 MAs published in psychology and related
fields. Our results also highlight that AMSTAR 2 is subject
to a floor effect, as evidenced by the fact that 95% of our
sample was rated as critically low, which is the lowest cate-
gory proposed by the tool. Therefore, the discriminative ca-
pacity of this tool is not optimal, and additional
investigations of the AMSTAR 2, aiming to take this issue
into account, should be encouraged.
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Fig. 1. Validity results. Panel A present the pie chart of the overall judg-
ments forAMSTARetAMSTAR2.PanelBpresent thebar chart illustrating
theconcordanceof theoverall judgments forboth tools.PanelCpresent the
correlation of the number of items fulfilled between the two tools.
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